• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A novel, effective, and efficient strategy for treating sickle cell vaso-occlusive events in the infusion center setting.

作者信息

Peslak Scott A, Akins Alexis Brimm, Foxwell Anessa M, Iannelli Marie, Grande Carolyn, Breen Delisha, Russell J Eric, Uritsky Tanya J, Sayani Farzana A

机构信息

Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

Clinical Practices of the University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia, PA.

出版信息

Blood Adv. 2023 Feb 14;7(3):410-413. doi: 10.1182/bloodadvances.2022007307.

DOI:10.1182/bloodadvances.2022007307
PMID:35939784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9979427/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bba/9979427/3028725f8972/BLOODA_ADV-2022-007307-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bba/9979427/3028725f8972/BLOODA_ADV-2022-007307-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bba/9979427/3028725f8972/BLOODA_ADV-2022-007307-gr1.jpg

相似文献

1
A novel, effective, and efficient strategy for treating sickle cell vaso-occlusive events in the infusion center setting.一种在输液中心环境中治疗镰状细胞血管闭塞性事件的新颖、有效且高效的策略。
Blood Adv. 2023 Feb 14;7(3):410-413. doi: 10.1182/bloodadvances.2022007307.
2
Double-stranded RNA induces sickle erythrocyte adherence to endothelium: a potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia.双链RNA诱导镰状红细胞黏附于内皮细胞：病毒感染在镰状细胞贫血血管阻塞性疼痛发作中的潜在作用。
Blood. 1995 May 15;85(10):2945-50.
3
Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department.急诊科中辅助低剂量氯胺酮治疗儿童和青年成人镰状细胞血管闭塞性发作
Br J Haematol. 2022 Jul;198(1):207-209. doi: 10.1111/bjh.18201. Epub 2022 Apr 9.
4
Outcomes of an Emergency Department Observation Unit-Based Pathway for the Treatment of Uncomplicated Vaso-occlusive Events in Sickle Cell Disease.以急诊科观察单元为基础的路径治疗镰状细胞病单纯血管阻塞性事件的结果。
Ann Emerg Med. 2020 Sep;76(3S):S12-S20. doi: 10.1016/j.annemergmed.2020.08.007.
5
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.DOVE（确定血小板抑制对血管闭塞事件的影响）试验设计：一项全球性3期双盲、随机、安慰剂对照、多中心研究，采用剂量滴定策略评估普拉格雷在镰状细胞贫血儿科患者中的疗效和安全性。
Pediatr Blood Cancer. 2016 Feb;63(2):299-305. doi: 10.1002/pbc.25771. Epub 2015 Sep 24.
6
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.慢病毒载体基因疗法 LentiGlobin 治疗镰状细胞病的生物学和临床疗效。
N Engl J Med. 2022 Feb 17;386(7):617-628. doi: 10.1056/NEJMoa2117175. Epub 2021 Dec 12.
7
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.一项评估普拉格雷治疗镰状细胞血管阻塞事件的多国临床试验。
N Engl J Med. 2016 Feb 18;374(7):625-35. doi: 10.1056/NEJMoa1512021. Epub 2015 Dec 8.
8
Platelet count decline and high neutrophil count within the first day of admission for painful sickle cell vaso-occlusive episodes predict severe complications.在疼痛性镰状细胞血管阻塞性发作入院第一天内血小板计数下降和中性粒细胞计数升高预示着严重并发症。
Br J Haematol. 2023 Aug;202(3):e20-e23. doi: 10.1111/bjh.18898. Epub 2023 May 29.
9
Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.镰状细胞血管闭塞危象期间氧化应激的加剧与抗带3自身抗体率降低和红细胞衍生微粒水平升高相关：一项前瞻性研究。
Br J Haematol. 2017 Mar;176(5):805-813. doi: 10.1111/bjh.14476. Epub 2016 Dec 16.
10
Unusual causes of abdominal pain: sickle cell anemia.腹痛的罕见病因：镰状细胞贫血。
Best Pract Res Clin Gastroenterol. 2005 Apr;19(2):297-310. doi: 10.1016/j.bpg.2004.11.007.

引用本文的文献

1
Impact of Individualized Versus Weight-Based Pain Protocols on Patient Satisfaction for Patients With Sickle Cell Disease Experiencing a Vaso-Occlusive Episode.个体化与基于体重的疼痛治疗方案对镰状细胞病血管闭塞性发作患者满意度的影响。
J Emerg Nurs. 2025 Jul;51(4):626-635. doi: 10.1016/j.jen.2024.12.014. Epub 2025 Feb 27.
2
A telemedicine triage model for infusion center-based management of adult sickle cell pain episodes.一种基于远程医疗分诊模型的成人镰状细胞性疼痛发作输液中心管理模式。
Blood Adv. 2025 Feb 11;9(3):603-605. doi: 10.1182/bloodadvances.2024013973.

本文引用的文献

1
Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study.在输液中心与急诊科治疗镰状细胞病成人急性疼痛：一项多中心前瞻性队列研究。
Ann Intern Med. 2021 Sep;174(9):1207-1213. doi: 10.7326/M20-7171. Epub 2021 Jul 6.
2
Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects.建立成人镰状细胞病的医疗服务可及性：定义照护模式、基本要素和经济方面。
Blood Adv. 2020 Aug 25;4(16):3804-3813. doi: 10.1182/bloodadvances.2020001743.
3
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.
美国血液学会2020年镰状细胞病指南：急性和慢性疼痛的管理
Blood Adv. 2020 Jun 23;4(12):2656-2701. doi: 10.1182/bloodadvances.2020001851.
4
Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.成人疼痛性镰状细胞血管闭塞性危象的药物干预措施。
Cochrane Database Syst Rev. 2019 Nov 14;2019(11):CD012187. doi: 10.1002/14651858.CD012187.pub2.
5
Increased acute care utilization in a prospective cohort of adults with sickle cell disease.前瞻性队列研究中镰状细胞病成人患者急性护理利用增加。
Blood Adv. 2018 Sep 25;2(18):2412-2417. doi: 10.1182/bloodadvances.2018018382.
6
Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis.设立专门输液诊所对镰状细胞疼痛危象成年患者进行急性处理的影响
Am J Hematol. 2015 May;90(5):376-80. doi: 10.1002/ajh.23961. Epub 2015 Feb 25.
7
Quality improvement process in a sickle cell infusion center.镰状细胞输注中心的质量改进流程。
Am J Med. 2015 May;128(5):541-4. doi: 10.1016/j.amjmed.2014.11.020. Epub 2014 Dec 9.
8
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.镰状细胞病的管理：专家小组成员 2014 年循证报告的总结。
JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517.
9
Effectiveness of a dedicated day hospital for management of acute sickle cell pain.一家专门的日间医院对急性镰状细胞疼痛的管理效果。
Haematologica. 2007 Jun;92(6):854-5. doi: 10.3324/haematol.10757.
10
Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises.镰状细胞贫血日间医院：一种处理单纯性疼痛危象的方法。
Blood. 2000 Feb 15;95(4):1130-6.